G Rufı́

3.2k total citations
42 papers, 1.9k citations indexed

About

G Rufı́ is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, G Rufı́ has authored 42 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 19 papers in Infectious Diseases and 11 papers in Surgery. Recurrent topics in G Rufı́'s work include Tuberculosis Research and Epidemiology (7 papers), Infectious Diseases and Tuberculosis (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). G Rufı́ is often cited by papers focused on Tuberculosis Research and Epidemiology (7 papers), Infectious Diseases and Tuberculosis (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). G Rufı́ collaborates with scholars based in Spain and United States. G Rufı́'s co-authors include Román Pallarés, Javier Ariza, Josefina Liñares, Pedro F. Viladrich, Francisco Gudiol, P. F. Viladrich, F. Gudiol, Francesc Gudiol, Jordi Dorca and P Fernández-Viladrich and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Clinical Infectious Diseases.

In The Last Decade

G Rufı́

41 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Rufı́ Spain 20 1.3k 571 519 327 241 42 1.9k
F. Gudiol Spain 26 1.1k 0.9× 336 0.6× 611 1.2× 176 0.5× 202 0.8× 45 2.3k
Edward J. Young United States 29 979 0.8× 471 0.8× 768 1.5× 126 0.4× 220 0.9× 79 2.3k
P. F. Viladrich Spain 15 764 0.6× 209 0.4× 233 0.4× 414 1.3× 199 0.8× 23 1.1k
Robert W. Bradsher United States 29 2.9k 2.3× 2.6k 4.6× 595 1.1× 140 0.4× 313 1.3× 85 3.8k
Pedro F. Viladrich Spain 16 1.3k 1.0× 349 0.6× 132 0.3× 579 1.8× 330 1.4× 26 1.8k
Petra Apfalter Austria 22 706 0.5× 403 0.7× 104 0.2× 425 1.3× 163 0.7× 63 1.6k
Myles E. Gombert United States 23 617 0.5× 309 0.5× 244 0.5× 150 0.5× 103 0.4× 39 1.3k
M Y Khan Saudi Arabia 20 892 0.7× 347 0.6× 787 1.5× 92 0.3× 102 0.4× 35 1.5k
Carmen Quereda Spain 32 1.8k 1.4× 1.6k 2.8× 105 0.2× 126 0.4× 245 1.0× 132 3.4k
Chen‐Hsiang Lee Taiwan 29 790 0.6× 777 1.4× 147 0.3× 121 0.4× 163 0.7× 145 2.5k

Countries citing papers authored by G Rufı́

Since Specialization
Citations

This map shows the geographic impact of G Rufı́'s research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Rufı́ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Rufı́ more than expected).

Fields of papers citing papers by G Rufı́

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Rufı́. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Rufı́. The network helps show where G Rufı́ may publish in the future.

Co-authorship network of co-authors of G Rufı́

This figure shows the co-authorship network connecting the top 25 collaborators of G Rufı́. A scholar is included among the top collaborators of G Rufı́ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Rufı́. G Rufı́ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gil‐Vernet, Salvador, Helena Colom, L. Pou, et al.. (2009). Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics. Transplant Infectious Disease. 12(3). 204–212. 17 indexed citations
2.
Gavaldà, Joan, Óscar Len, Rafael San Juan, et al.. (2005). Risk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control Study. Clinical Infectious Diseases. 41(1). 52–59. 217 indexed citations
3.
Rafecas, Antonio, G Rufı́, Juan Figueras, et al.. (2004). Liver transplantation without steroid induction in HIV-infected patients. Liver Transplantation. 10(10). 1320–1323. 18 indexed citations
4.
Santín, Miguel, Fernando Alcaide, Miguel Ángel Benítez, et al.. (2004). Incidence and molecular typing of Mycobacterium kansasii in a defined geographical area in Catalonia, Spain. Epidemiology and Infection. 132(3). 425–432. 17 indexed citations
5.
Mateo, Lourdes, G Rufı́, Joan M. Nolla, & Fernando Alcaide. (2004). Mycobacterium chelonae tenosynovitis of the hand. Seminars in Arthritis and Rheumatism. 34(3). 617–622. 20 indexed citations
6.
Jaurrieta, Eduardo, L Casais, Juan Figueras, et al.. (2000). Análisis de 500 trasplantes hepáticos en el Hospital de Bellvitge. Medicina Clínica. 115(14). 521–529. 16 indexed citations
7.
Almeda, Jesús, Albert García-Quintanilla, J. González, et al.. (2000). Clinical Evaluation of an In-House IS 6110 Polymerase Chain Reaction for Diagnosis of Tuberculosis. European Journal of Clinical Microbiology & Infectious Diseases. 19(11). 859–867. 27 indexed citations
8.
Hueso, Miguel, Jordi Bover, Salvador Gil‐Vernet, et al.. (1999). The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate—cure with ketoconazole and allopurinol. Nephrology Dialysis Transplantation. 14(12). 2941–2943. 21 indexed citations
9.
Podzamczer, D, Elena Ferrer, Albert García-Quintanilla, et al.. (1997). pp65 Antigenemia as a Marker of Future CMV Disease and Mortality in HIV-infected Patients. Scandinavian Journal of Infectious Diseases. 29(3). 223–227. 15 indexed citations
10.
Ariza, Javier, Juan Corredoira, Román Pallarés, et al.. (1995). Characteristics of and Risk Factors for Relapse of Brucellosis in Humans. Clinical Infectious Diseases. 20(5). 1241–1249. 141 indexed citations
11.
Santín, Miguel, D Podzamczer, José M. Mascaró, et al.. (1995). Utility of the Gallium-67 Citrate Scan for the Early Diagnosis of Tuberculosis in Patients Infected with the Human Immunodeficiency Virus. Clinical Infectious Diseases. 20(3). 652–656. 12 indexed citations
12.
13.
Corbella, Xavier, Miquel Vadillo, Carmen Cabellos, P Fernández-Viladrich, & G Rufı́. (1995). Hypersensitivity Hepatitis due to Pyrazinamide. Scandinavian Journal of Infectious Diseases. 27(1). 93–94. 8 indexed citations
14.
Ariza, Javier, Román Pallarés, Jordi Carratalà, et al.. (1994). Gram-negative bacillary cellulitis in patients with hepatic cirrhosis. European Journal of Clinical Microbiology & Infectious Diseases. 13(1). 19–24. 46 indexed citations
15.
Ariza, Javier, Miquel Pujol, J. Valverde, et al.. (1993). Brucellar Sacroiliitis: Findings in 63 Episodes and Current Relevance. Clinical Infectious Diseases. 16(6). 761–765. 65 indexed citations
16.
Ariza, Javier, et al.. (1992). Treatment of Human Brucellosis with Doxycycline plus Rifampin or Doxycycline plus Streptomycin. Annals of Internal Medicine. 117(1). 25–30. 149 indexed citations
17.
Viladrich, Pedro F., Francisco Gudiol, Josefina Liñares, et al.. (1988). Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. The American Journal of Medicine. 84(5). 839–846. 133 indexed citations
18.
Gudiol, F., Román Pallarés, Xavier Ariza, et al.. (1986). Comparative clinical evaluation of aztreonam versus aminoglycosides in Gram-negative septicaemia. Journal of Antimicrobial Chemotherapy. 17(5). 661–671. 13 indexed citations
19.
Arruga, Jorge, et al.. (1985). Neuroretinitis in Acquired Syphilis. Ophthalmology. 92(2). 262–270. 49 indexed citations
20.
Rufı́, G, et al.. (1976). Neurological manifestations in a patient with filariasis.. BMJ. 2(6042). 978.2–979. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Gudiol Breakdown of academic impact, for papers by Edward J. Young Breakdown of academic impact, for papers by P. F. Viladrich Breakdown of academic impact, for papers by Robert W. Bradsher Breakdown of academic impact, for papers by Pedro F. Viladrich Breakdown of academic impact, for papers by Petra Apfalter Breakdown of academic impact, for papers by Myles E. Gombert Breakdown of academic impact, for papers by M Y Khan Breakdown of academic impact, for papers by Carmen Quereda Breakdown of academic impact, for papers by Chen‐Hsiang Lee
Rankless by CCL
2026